The Big Cancer52 Conversation

The Big Cancer52 Conversation kicked off this month at Level39, bringing together delegates from cross-sector organisations across the wider rare and less common cancer community.

The day was opened by Canary Wharf Group CEO, Shobi Khan, and led by Cancer52 CEO, Jane Lyons. The Big Cancer52 Conversation brought together cancer charities, pharmaceutical companies, the NHS, UK Government, and the tech world, to discuss the opportunities ahead and how to make the most of them. There was a fantastic energy in the room as different sectors sought collaborative opportunities, with the overall aim of improving outcomes for those affected by rare and less common cancers.

Cancer52 is the common voice for rare and less common cancers, which account for 47% of diagnoses yet 55% of UK cancer deaths. Despite this, these cancers remain severely under represented across all areas, including policy, services and research. The Cancer52 alliance of over 100 cancer charities work together on matters that impact on the rare and less common cancer community – defined as all cancers outside the ‘big four’ of breast, prostate, lung and bowel. If you would like to support the work of Cancer52, you can donate online.

Level39 and The Cancer Awareness Trust were pleased to support the event by providing the venue for Cancer52 and we look forward to working together to identify next steps and maximise the impact of this event. 


Related News